Latest epilepsy Stories
-- Primary efficacy and safety data from the largest Phase 3 brivaracetam study involving 768 patients presented at the 68th Annual Meeting of the American Epilepsy Society BRUSSELS, Dec.
-- Results of Investigational Studies of Perampanel and Rufinamide Accepted as Late-Breaking Posters -- WOODCLIFF LAKE, N.J., Dec. 5, 2014 /PRNewswire/ -- Eisai Inc.
MINNEAPOLIS, Dec. 5, 2014 /PRNewswire-USNewswire/ -- Today the Child Neurology Foundation (CNF), named Elizabeth A.
- Atlanta-based Collaboration Will Explore the Potential of Big Data to Help Inform Treatment Decisions for People Living with Epilepsy ATLANTA, Dec.
- 24 UCB-sponsored presentations including new data on VIMPAT® (lacosamide) BRUSSELS, Dec.
Digital marketing agency promises $1,000 to students with epilepsy. ATLANTA, GA (PRWEB) November 26, 2014 EverSpark Interactive, a full service digital
PORTLAND, Oregon, November 25, 2014 /PRNewswire/ -- According to a new report by Allied Market Research titled, "Global Neuroprosthetics Market (Product Types, Technology,
* Announces March 1-7 2015 as KCNQ2 Awareness Week * Initiates International KCNQ2 Encephalopathy Patient Registry * Today families of children with KCNQ2, together with leading scientists, launched
Nationwide, fundraising and charity events are held in hopes to raise awareness and funds to further research treatments and better understand the diseases in order to create a better future for
HOUSTON, Nov. 24, 2014 /PRNewswire/ -- Cyberonics, Inc.
- totally perplexed and mixed up.